ARCHIVES

Surgery Lowers Risk By 90% In Women With Gene Mutations

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

RFAs Available

February 23, 1996

NCI Offers Informations, Resources, To Industry.

April 6, 2001

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010